Goldman Sachs Group Inc Pear Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 14, 2024	SELL	$0.21 - $1.24 $489 - $2,889	-2,330 Reduced 7.09%	30,549 $7,000
Q1 2023 May 11, 2023	SELL	$0.21 - $1.24 $489 - $2,889	-2,330 Reduced 7.09%	30,549 $7,000
Q4 2022 May 14, 2024	BUY	$0.99 - $2.91 $32,550 - $95,677	32,879 New	32,879 $38,000
Q4 2022 Feb 13, 2023	BUY	$0.99 - $2.91 $32,550 - $95,677	32,879 New	32,879 $38,000
Q2 2022 Aug 15, 2022	SELL	$1.54 - $6.48 $24,054 - $101,217	-15,620 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.67 - $7.63 $57,325 - $119,180	15,620 New	15,620 $79,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.